Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 78/100

Tandem Diabetes Care Inc at Morgan Stanley Healthcare Conference Transcript

Sep 11, 2019 / 02:30PM GMT
Release Date Price: €56.42 (+5.42%)
Marissa Elizabeth Bych
Morgan Stanley, Research Division - Research Associate

Hi, we're on the clock, so I think we can go ahead and get started.

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

All right.

Marissa Elizabeth Bych
Morgan Stanley, Research Division - Research Associate

Good morning, everyone. My name is Marissa Bych, I am a medical technology research associate on David Lewis' team at Morgan Stanley. And so I'm with Tandem Diabetes this morning. We have John Sheridan, the President and CEO; and we also have Leigh Vosseller, the EVP and CFO of the company with us. Very excited to have you both with us today.

Questions & Answers

Marissa Elizabeth Bych
Morgan Stanley, Research Division - Research Associate

If we could start off, what is Tandem, briefly for those who may be less familiar? And then talk to us at a high level about what has changed for your company? Over the past 1 to 2 years, you've launched a new product

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot